Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
2,870.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
2,870.00
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
-190.00
-221.00
-159.00
-105.00
-247.00
Raw Materials Consumed
4,634.00
4,582.00
3,778.00
3,141.00
2,530.00
2,584.00
Power & Fuel Cost
52.00
45.00
31.00
17.00
13.00
13.00
Employee Cost
726.00
625.00
545.00
393.00
338.00
272.00
Operating Expenses
100.00
82.00
65.00
44.00
28.00
32.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
43.00
51.00
35.00
30.00
19.00
23.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
7.00
6.00
5.00
4.00
1.00
37.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,648.00
5,270.00
4,291.00
3,506.00
2,852.00
2,736.00
Operating Profit (PBDIT) excl Other Income
487.00
354.00
265.00
272.00
216.00
133.00
Other Income
48.00
40.00
46.00
31.00
21.00
17.00
Operating Profit (PBDIT)
535.00
394.00
311.00
303.00
238.00
150.00
Interest
102.00
96.00
83.00
66.00
54.00
46.00
Profit before Depriciation and Tax
433.00
297.00
228.00
237.00
183.00
104.00
Depreciation
249.00
224.00
181.00
119.00
88.00
74.00
Profit Before Taxation & Exceptional Items
183.00
73.00
47.00
117.00
95.00
29.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
183.00
73.00
47.00
117.00
95.00
29.00
Provision for Tax
33.00
7.00
-2.00
23.00
31.00
27.00
Profit After Tax
150.00
65.00
50.00
94.00
63.00
1.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
279.00
213.00
163.00
66.00
1.00
1.00
Profit Available for appropriations
429.00
279.00
213.00
161.00
65.00
4.00
Appropriations
429.00
279.00
213.00
161.00
65.00
4.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
12.57
5.48
4.17
8.55
6.13
1.05
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 9.09% vs 23.42% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 37.57% vs 33.28% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 6.38% vs 16.15% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 129.09% vs 30.88% in Mar 2024
Compare Profit and Loss Results of Medplus Health
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,136.00
7,829.00
-1,693.00
-21.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,136.00
7,829.00
-1,693.00
-21.62%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
140.00
-134.00
-95.71%
Raw Materials Consumed
4,634.00
3,131.00
1,503.00
48.00%
Power & Fuel Cost
52.00
88.00
-36.00
-40.91%
Employee Cost
726.00
918.00
-192.00
-20.92%
Operating Expenses
100.00
681.00
-581.00
-85.32%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
43.00
472.00
-429.00
-90.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
7.00
61.00
-54.00
-88.52%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,648.00
6,606.00
-958.00
-14.50%
Operating Profit (PBDIT) excl Other Income
487.00
1,223.00
-736.00
-60.18%
Other Income
48.00
77.00
-29.00
-37.66%
Operating Profit (PBDIT)
535.00
1,300.00
-765.00
-58.85%
Interest
102.00
413.00
-311.00
-75.30%
Profit before Depriciation and Tax
433.00
887.00
-454.00
-51.18%
Depreciation
249.00
705.00
-456.00
-64.68%
Profit Before Taxation & Exceptional Items
183.00
181.00
2.00
1.10%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
183.00
83.00
100.00
120.48%
Provision for Tax
33.00
23.00
10.00
43.48%
Profit After Tax
150.00
59.00
91.00
154.24%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
279.00
0.00
279.00
0%
Profit Available for appropriations
429.00
59.00
370.00
627.12%
Appropriations
429.00
59.00
370.00
627.12%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
12.57
0.49
12.08
2,465.31%
Profit And Loss - Net Sales
Net Sales 6,136.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.09% vs 23.42% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 487.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.57% vs 33.28% in Mar 2024
Profit And Loss - Interest
Interest 102.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.38% vs 16.15% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 150.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 129.09% vs 30.88% in Mar 2024






